BamSEC and AlphaSense Join Forces
Learn More

Surface Oncology Inc

Formerly NASDAQ: SURF
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 8 pages Lease Termination Agreement
12/34/56
EX-10.4
from 8-K 3 pages June [•], 2023 To: [•] Re: Retention Agreement Dear [•]: I. Retention Bonus
12/34/56
EX-10.3
from 8-K 4 pages First Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 3 pages First Amendment to Employment Agreement
12/34/56
EX-10.11
from 10-K 14 pages Surface Oncology, Inc. 2021 Inducement Plan
12/34/56
EX-10.2
from 10-Q 2 pages Amendment No. 1 to License Agreement
12/34/56
EX-10.4
from 10-Q 28 pages Exclusive Product License Agreement
12/34/56
EX-10.1
from 8-K 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.2
from 8-K 13 pages Amended and Restated Employment Agreement
12/34/56
EX-10.1
from 8-K 10 pages February 9, 2021 Jeff Goater Re: Transition and CEO Support Agreement Dear Jeff: 1. Transition Plan
12/34/56
EX-10.22
from 10-K 30 pages This Sublease Agreement (This “Sublease”), Made as of December 16, 2019 (The “Effective Date”), by and Between Surface Oncology, Inc., a Delaware Corporation (“Sublessor”), and Eqrx, Inc., a Delaware Corporation (Hereinafter Referred to as “Sublessee”);
12/34/56
EX-10
from 10-Q 60 pages First Amended and Restated Development and Option Agreement
12/34/56
EX-10
from 10-Q 3 pages Fourth Amendment to Collaboration Agreement
12/34/56
EX-10.1
from 8-K 26 pages Second Amendment to Lease
12/34/56
EX-10.15
from S-1/A 2 pages March 30, 2018 Daniel S. Lynch Re: Contingent Employment Agreement Termination Letter Dear Dan: Reference Is Hereby Made to That Certain Employment Agreement (The “Agreement”) Dated as of November 23, 2016, by and Between Surface Oncology, Inc. (The “Company”), and You
12/34/56
EX-10.15
from S-1/A 2 pages March 30, 2018 Daniel S. Lynch Re: Contingent Employment Agreement Termination Letter Dear Dan: Reference Is Hereby Made to That Certain Employment Agreement (The “Agreement”) Dated as of November 23, 2016, by and Between Surface Oncology, Inc. (The “Company”), and You
12/34/56
EX-10.22
from S-1 14 pages Surface Oncology, Inc. Form of Officer Indemnification Agreement
12/34/56
EX-10.21
from S-1 14 pages Surface Oncology, Inc. Form of Director Indemnification Agreement
12/34/56
EX-10.20
from S-1 64 pages Development and Option Agreement
12/34/56
EX-10.19
from S-1 18 pages Article 1 Definitions
12/34/56